- Home
- CALC vs AXDX Comparison
CALC vs AXDX Comparison
Compare CALC & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- AXDX
- Stock Information
- Founded
- CALC 2011
- AXDX 1982
- Country
- CALC United States
- AXDX United States
- Employees
- CALC N/A
- AXDX N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- AXDX Biotechnology: Laboratory Analytical Instruments
- Sector
- CALC Health Care
- AXDX Industrials
- Exchange
- CALC Nasdaq
- AXDX Nasdaq
- Market Cap
- CALC 44.7M
- AXDX 44.5M
- IPO Year
- CALC N/A
- AXDX 1996
- Fundamental
- Price
- CALC $3.35
- AXDX $1.88
- Analyst Decision
- CALC Strong Buy
- AXDX Hold
- Analyst Count
- CALC 4
- AXDX 1
- Target Price
- CALC $19.50
- AXDX $1.00
- AVG Volume (30 Days)
- CALC 89.5K
- AXDX 62.8K
- Earning Date
- CALC 11-13-2024
- AXDX 11-07-2024
- Dividend Yield
- CALC N/A
- AXDX N/A
- EPS Growth
- CALC N/A
- AXDX N/A
- EPS
- CALC N/A
- AXDX N/A
- Revenue
- CALC N/A
- AXDX $11,909,000.00
- Revenue This Year
- CALC N/A
- AXDX $1.42
- Revenue Next Year
- CALC N/A
- AXDX $4.09
- P/E Ratio
- CALC N/A
- AXDX N/A
- Revenue Growth
- CALC N/A
- AXDX N/A
- 52 Week Low
- CALC $2.68
- AXDX $0.73
- 52 Week High
- CALC $8.38
- AXDX $5.78
- Technical
- Relative Strength Index (RSI)
- CALC 40.56
- AXDX 46.64
- Support Level
- CALC $3.35
- AXDX $1.77
- Resistance Level
- CALC $3.60
- AXDX $2.04
- Average True Range (ATR)
- CALC 0.26
- AXDX 0.10
- MACD
- CALC -0.03
- AXDX -0.01
- Stochastic Oscillator
- CALC 4.35
- AXDX 13.56
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.